Tags

Type your tag names separated by a space and hit enter

BAL inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis.
Chest. 2020 Jul 02 [Online ahead of print]Chest

Abstract

BACKGROUND

Pulmonary exacerbations in cystic fibrosis are characterized by airway inflammation and may cause irreversible lung damage. Early identification of such exacerbations may facilitate early initiation of treatment, thereby potentially reducing long-term morbidity.

RESEARCH QUESTION

Is it possible to predict pulmonary exacerbations in children with cystic fibrosis using inflammatory markers obtained from bronchoalveolar lavage (BAL) fluid?

STUDY DESIGN

and Methods: A longitudinal analysis of children aged 0-7 years included in the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) study between 2005 and 2015. The association between inflammatory markers from annual BAL fluid and time to pulmonary exacerbation requiring hospital admission in the six-month period post-BAL was analysed using Kaplan-Meier curves and Weibull regression, adjusting for annually repeated measurements. Admissions for Pseudomonas eradication were excluded in the main analysis, due to the standard policy in participating centres to treat Pseudomonas in-hospital.

RESULTS

976 BAL samples from 308 children were analysed. After exclusion of admissions for Pseudomonas eradication (n=43), there were 145 pulmonary exacerbations recorded within six months of BAL; median time-to-exacerbation was 31 days (interquartile range 9-100). In univariate analyses, high interleukin-8 (hazard ratio (HR) 2.25 for 75th vs. 25th percentile, 95%-CI 1.87-2.72), neutrophil elastase (HR) 3.00, 95%-CI 2.03-4.42), and high neutrophil percentage (HR 1.80 for 75th vs. 25th percentile, 95%-CI 1.56-2.04) were all significantly associated with risk for a pulmonary exacerbation (p<0.001). The inflammatory markers remained significant predictors after adjustment for clinical predictive variables.

INTERPRETATION

Inflammatory markers in BAL fluid are significant predictors of pulmonary exacerbations in young children with cystic fibrosis. The development of non-invasive measures of lung inflammation may facilitate routine surveillance of cystic fibrosis.

Authors+Show Affiliations

Department of Respiratory and Sleep Medicine, Perth Children's Hospital, Perth, Australia; Telethon Kids Institute, Perth, Australia.Department of Respiratory and Sleep Medicine, Perth Children's Hospital, Perth, Australia; Telethon Kids Institute, Perth, Australia.Telethon Kids Institute, Perth, Australia.Murdoch Children's Research Institute, Parkville, Australia; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Australia; Department of Paediatrics, University of Melbourne, Parkville, Australia.Murdoch Children's Research Institute, Parkville, Australia; Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Australia.Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Australia; Department of Paediatrics, University of Melbourne, Parkville, Australia.Child Health Research Centre, University of Queensland, Brisbane, Australia.Telethon Kids Institute, Perth, Australia; Department of Paediatrics and Respiratory Medicine, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands. Electronic address: d.caudri@erasmusmc.nl.Department of Respiratory and Sleep Medicine, Perth Children's Hospital, Perth, Australia; Telethon Kids Institute, Perth, Australia.No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32622821

Citation

Ishak, Alya, et al. "BAL Inflammatory Markers Can Predict Pulmonary Exacerbations in Children With Cystic Fibrosis." Chest, 2020.
Ishak A, Stick SM, Turkovic L, et al. BAL inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis. Chest. 2020.
Ishak, A., Stick, S. M., Turkovic, L., Ranganathan, S. C., King, L., Harrison, J., Sly, P. D., Caudri, D., & Schultz, A. (2020). BAL inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis. Chest. https://doi.org/10.1016/j.chest.2020.06.044
Ishak A, et al. BAL Inflammatory Markers Can Predict Pulmonary Exacerbations in Children With Cystic Fibrosis. Chest. 2020 Jul 2; PubMed PMID: 32622821.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - BAL inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis. AU - Ishak,Alya, AU - Stick,Stephen M, AU - Turkovic,Lidija, AU - Ranganathan,Sarath C, AU - King,Louise, AU - Harrison,Joanne, AU - Sly,Peter D, AU - Caudri,Daan, AU - Schultz,André, AU - ,, Y1 - 2020/07/02/ PY - 2019/12/19/received PY - 2020/06/12/revised PY - 2020/06/17/accepted PY - 2020/7/6/entrez PY - 2020/7/6/pubmed PY - 2020/7/6/medline JF - Chest JO - Chest N2 - BACKGROUND: Pulmonary exacerbations in cystic fibrosis are characterized by airway inflammation and may cause irreversible lung damage. Early identification of such exacerbations may facilitate early initiation of treatment, thereby potentially reducing long-term morbidity. RESEARCH QUESTION: Is it possible to predict pulmonary exacerbations in children with cystic fibrosis using inflammatory markers obtained from bronchoalveolar lavage (BAL) fluid? STUDY DESIGN: and Methods: A longitudinal analysis of children aged 0-7 years included in the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) study between 2005 and 2015. The association between inflammatory markers from annual BAL fluid and time to pulmonary exacerbation requiring hospital admission in the six-month period post-BAL was analysed using Kaplan-Meier curves and Weibull regression, adjusting for annually repeated measurements. Admissions for Pseudomonas eradication were excluded in the main analysis, due to the standard policy in participating centres to treat Pseudomonas in-hospital. RESULTS: 976 BAL samples from 308 children were analysed. After exclusion of admissions for Pseudomonas eradication (n=43), there were 145 pulmonary exacerbations recorded within six months of BAL; median time-to-exacerbation was 31 days (interquartile range 9-100). In univariate analyses, high interleukin-8 (hazard ratio (HR) 2.25 for 75th vs. 25th percentile, 95%-CI 1.87-2.72), neutrophil elastase (HR) 3.00, 95%-CI 2.03-4.42), and high neutrophil percentage (HR 1.80 for 75th vs. 25th percentile, 95%-CI 1.56-2.04) were all significantly associated with risk for a pulmonary exacerbation (p<0.001). The inflammatory markers remained significant predictors after adjustment for clinical predictive variables. INTERPRETATION: Inflammatory markers in BAL fluid are significant predictors of pulmonary exacerbations in young children with cystic fibrosis. The development of non-invasive measures of lung inflammation may facilitate routine surveillance of cystic fibrosis. SN - 1931-3543 UR - https://www.unboundmedicine.com/medline/citation/32622821/BAL_inflammatory_markers_can_predict_pulmonary_exacerbations_in_children_with_cystic_fibrosis L2 - https://linkinghub.elsevier.com/retrieve/pii/S0012-3692(20)31838-9 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.